Clinical Trials Directory

Trials / Unknown

UnknownNCT02235935

The Effect of Hyperbaric Chamber Treatment on Patients With Diabetic Retinopathy

Status
Unknown
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Assaf-Harofeh Medical Center · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Diabetic retinopathy (DR) is a common complication of diabetes and is divided into non proliferative DR and proliferative DR. The damage is caused by either macular edema, macular ischemia that can be followed by vascular proliferation. Hyperbaric chamber treatment assists in increasing the amount of oxygen in the plasma and in the tissues and has been proven to be beneficial in treating different wounds in diabetic patients but its effect hasn't been tested in diabetic retinopathy yet. This study will recruit 40 diabetic patients who are scheduled for hyperbaric treatment due to different indications such as chronic wounds or radiation damages and who also have diabetic retinopathy. These patients will undergo opthalmic physical examination including fundus photography and OCT (Optical Coherence Tomography - optical IR retinal photography). Screening for these patients will be conducted at the Hyperbaric chamber at Assaf Harofe Medical Center for all diabetic patients prior to their first treatment.

Conditions

Timeline

Start date
2014-09-01
Primary completion
2015-09-01
Completion
2016-09-01
First posted
2014-09-10
Last updated
2014-09-10

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02235935. Inclusion in this directory is not an endorsement.